SoMex Research & Health
Pvt. Ltd.
+91-141-2504996           
banner11 banner22 banner33 banner44

News & Events


Emerging evidence of Nimotuzumab (BioMab EGFR) in Esophageal Cancers

(2-November-2012)
Safety and efficacy of anti EGF receptor humanized monoclonal antibody Nimotuzumab in unresectable esophoageal tumors in combination with chemo-radiotherapy: Phase II clinical trial final results one quite impresive.



Other News